


| Key | % Net Assets |
|---|---|
| 8.4% | |
| 7.9% | |
| 7.6% | |
| 5.2% | |
| 70.9% |
| Name | % Net Assets |
|---|---|
| BP | 8.4% |
| HSBC | 7.9% |
| BP | 7.6% |
| GlaxoSmithKline | 5.2% |
| GlaxoSmithKline | 5.0% |
| Astrazeneca | 3.5% |
| BHP Billiton | 3.1% |
| Rio Tinto | 3.1% |
| Standard Chartered | 2.9% |
| BG Group | 2.7% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 31/10/1995 |
|---|---|
| Fund Manager | Batterymarch Financial Management |
| TER | 1.80 (31-Aug-2010) |
| Minimum Investment | |
|---|---|
| Initial | 3000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.05 |
You are here: research